P2 Science appoints Oihana Elizalde, PhD as Chief Executive Officer
Green chemistry company P2 Science announced today the appointment of Oihana Elizalde, PhD as Chief Executive Officer effective November 27, 2023. Oihana joins P2 after having served as Head of Sales for BASF Personal Care North America, and VP / General Manager of...CellFE secures $22 million in Series A financing
Sept 27, 2023 CellFE announced the completion of a $22 million Series A financing, led by M Ventures. Great Point Ventures and Riverine Ventures also invested as well as existing investors Cota Capital, Dynamk Capital, Elm Street Ventures, Embark Ventures, EGB...Yale Announces Major Upgrade to Engineering Campus
Feb 23, 2023 Yale University announced a major initiative to significantly rebuild the School of Engineering’s physical infrastructure over the next 12 years....Desmos Sells Curriculum Business to Amplify Education and Spins Out Desmos Studio PBC
May 18, 2022 Desmos and Amplify Education announced that the math curriculum being developed by Desmos will become part of the digital education portfolio of Amplify, a major digital educational software provider....Elm Street Ventures’ Portfolio Company Saphlux, Inc. Raises $5 Million in Additional Funding
Elm Street Ventures announced today that it has increased its investment in Saphlux, Inc. as part of a $5 million Series AA financing round.
P2 Science closes Series B financing; will build manufacturing plant in New Haven
P2 Science closed a $9.6 million Series B financing and will build a manufacturing plant in New Haven.
Elm Street Ventures backs Yale Spin-out Artizan BioSciences
Elm Street Ventures announced that it has invested in Artizan Biosciences, Inc. as part of a $5 million Series A financing round. The financing was led by Hatteras Venture Partners.